These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23123908)

  • 1. Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli.
    Paul S; Linardopoulou EV; Billig M; Tchesnokova V; Price LB; Johnson JR; Chattopadhyay S; Sokurenko EV
    J Bacteriol; 2013 Jan; 195(2):231-42. PubMed ID: 23123908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.
    Nicolas-Chanoine MH; Petitjean M; Mora A; Mayer N; Lavigne JP; Boulet O; Leflon-Guibout V; Blanco J; Hocquet D
    BMC Microbiol; 2017 Mar; 17(1):71. PubMed ID: 28347271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.
    Johnson JR; Tchesnokova V; Johnston B; Clabots C; Roberts PL; Billig M; Riddell K; Rogers P; Qin X; Butler-Wu S; Price LB; Aziz M; Nicolas-Chanoine MH; Debroy C; Robicsek A; Hansen G; Urban C; Platell J; Trott DJ; Zhanel G; Weissman SJ; Cookson BT; Fang FC; Limaye AP; Scholes D; Chattopadhyay S; Hooper DC; Sokurenko EV
    J Infect Dis; 2013 Mar; 207(6):919-28. PubMed ID: 23288927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli.
    Weissman SJ; Chattopadhyay S; Aprikian P; Obata-Yasuoka M; Yarova-Yarovaya Y; Stapleton A; Ba-Thein W; Dykhuizen D; Johnson JR; Sokurenko EV
    Mol Microbiol; 2006 Feb; 59(3):975-88. PubMed ID: 16420365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.
    Adams-Sapper S; Diep BA; Perdreau-Remington F; Riley LW
    Antimicrob Agents Chemother; 2013 Jan; 57(1):490-7. PubMed ID: 23147723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli ST131-
    Liu CM; Stegger M; Aziz M; Johnson TJ; Waits K; Nordstrom L; Gauld L; Weaver B; Rolland D; Statham S; Horwinski J; Sariya S; Davis GS; Sokurenko E; Keim P; Johnson JR; Price LB
    mBio; 2018 Aug; 9(4):. PubMed ID: 30154256
    [No Abstract]   [Full Text] [Related]  

  • 7. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
    Rogers BA; Ingram PR; Runnegar N; Pitman MC; Freeman JT; Athan E; Havers S; Sidjabat HE; Gunning E; De Almeida M; Styles K; Paterson DL;
    Int J Antimicrob Agents; 2015 Apr; 45(4):351-8. PubMed ID: 25707371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
    Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fimH single-nucleotide polymorphisms for strain typing of clinical isolates of Escherichia coli for epidemiologic investigation.
    Dias RC; Moreira BM; Riley LW
    J Clin Microbiol; 2010 Feb; 48(2):483-8. PubMed ID: 20018817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Genomic Analysis of Globally Dominant ST131 Clone with Other Epidemiologically Successful Extraintestinal Pathogenic
    Shaik S; Ranjan A; Tiwari SK; Hussain A; Nandanwar N; Kumar N; Jadhav S; Semmler T; Baddam R; Islam MA; Alam M; Wieler LH; Watanabe H; Ahmed N
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066550
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection footprint in the FimH adhesin shows pathoadaptive niche differentiation in Escherichia coli.
    Sokurenko EV; Feldgarden M; Trintchina E; Weissman SJ; Avagyan S; Chattopadhyay S; Johnson JR; Dykhuizen DE
    Mol Biol Evol; 2004 Jul; 21(7):1373-83. PubMed ID: 15044596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of Enteroaggregative Escherichia coli within the ST131 Lineage as a Cause of Extraintestinal Infections.
    Boll EJ; Overballe-Petersen S; Hasman H; Roer L; Ng K; Scheutz F; Hammerum AM; Dungu A; Hansen F; Johannesen TB; Johnson A; Nair DT; Lilje B; Hansen DS; Krogfelt KA; Johnson TJ; Price LB; Johnson JR; Struve C; Olesen B; Stegger M
    mBio; 2020 May; 11(3):. PubMed ID: 32430467
    [No Abstract]   [Full Text] [Related]  

  • 15. Biofilm formation by multidrug resistant Escherichia coli ST131 is dependent on type 1 fimbriae and assay conditions.
    Sarkar S; Vagenas D; Schembri MA; Totsika M
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 17. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype.
    Johnson JR; Porter SB; Zhanel G; Kuskowski MA; Denamur E
    Infect Immun; 2012 Apr; 80(4):1554-62. PubMed ID: 22311928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.
    Johnson JR; Johnston B; Clabots C; Kuskowski MA; Castanheira M
    Clin Infect Dis; 2010 Aug; 51(3):286-94. PubMed ID: 20572763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.
    Platell JL; Cobbold RN; Johnson JR; Heisig A; Heisig P; Clabots C; Kuskowski MA; Trott DJ
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3782-7. PubMed ID: 21646486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls.
    Nielsen KL; Stegger M; Kiil K; Godfrey PA; Feldgarden M; Lilje B; Andersen PS; Frimodt-Møller N
    Int J Med Microbiol; 2017 Dec; 307(8):497-507. PubMed ID: 29031453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.